956204-54-9 Usage
General Description
(3-Methyl-4-nitro-pyrazol-1-yl)-acetic acid is a chemical compound that is commonly used in pharmaceutical research and development. It has potential applications in the field of medicine due to its anti-inflammatory and analgesic properties. (3-METHYL-4-NITRO-PYRAZOL-1-YL)-ACETIC ACID is also being studied for its potential use as a building block in the synthesis of new drugs for the treatment of various diseases. Additionally, (3-Methyl-4-nitro-pyrazol-1-yl)-acetic acid has shown promise in the development of new chemical entities and drug candidates. Overall, this chemical compound has significant potential to contribute to the advancement of medicine and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 956204-54-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,6,2,0 and 4 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 956204-54:
(8*9)+(7*5)+(6*6)+(5*2)+(4*0)+(3*4)+(2*5)+(1*4)=179
179 % 10 = 9
So 956204-54-9 is a valid CAS Registry Number.
956204-54-9Relevant articles and documents
1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
-
Page/Page column 101, (2010/12/29)
The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c] quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H- imidazo[4,5-c] quinofinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c] quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H- imidazo[4,5-c] quinolinone derivatives; and a process for the preparation of the novel 1H- imidazo[4,5-c] quinolinone derivatives.
